No anthrax vaccine testing on children -- for now

By RANDOLPH E. SCHMID , AP Science Writer

Should the anthrax vaccine be tested in children? It will be a while longer before the government decides.

An advisory board said Friday that need to be resolved - but if that can be accomplished the can be tested in children to be sure it's safe and to learn the proper dose in case it's needed in a .

Because of concerns that terrorists might use the potentially , the government has stockpiled the vaccine. It has been widely tested on adults but never on children.

The question is whether to do tests so doctors will know if children's immune systems respond to the shots well enough to signal protection. The children would not be exposed to anthrax.

The National Biodefense Science Board said Friday a separate review board should look into the ethical issues of doing such tests in children. If that is completed successfully, the panel, said, the Department of Health and Human Services should develop a plan for a study of the vaccine in children.

How to protect young people after an is a challenging issue, said Dr. Nicole Lurie, a member of the board and assistant secretary for preparedness and response at the Public Health Service. " still stands, for me, among the most important responsibilities that we have as a nation."

The board gives advice to the Department of Health and Human Services on preparations for chemical, biological and nuclear events. Its vote was 12-1.

There is no deadline for the government to decide whether to go along. And if it does agree, it's not clear how much time it would take to find money for such research and get clearance from review boards at medical centers that would conduct studies.

Another big question is whether parents would sign up their children to test a vaccine when there is no immediate threat. It's not possible to get anthrax from the vaccine, but there are side effects. In adults, shot-site soreness, muscle aches, and headache are the main ones, and rare but serious allergic reactions have been reported.

Anthrax is among several potential bioterror weapons and is of special interest because it was used in letters sent to the media and others in 2001, claiming five lives and sickening 17. That prompted extensive screening of mail and better ventilation and testing at postal facilities and government agencies.

The FBI has blamed the attacks-by-mail on Bruce Ivins, a scientist at an Army laboratory, who committed suicide before he could be charged.

Anthrax can be difficult to treat, especially if someone has breathed anthrax spores. Millions of doses of antibiotics have been stockpiled since the 2001 episode, and two experimental toxin-clearing treatments also are being stored.

U.S. troops deploying to Iraq, Afghanistan and some other countries are required to get anthrax shots. Since 1998, more than 1 million have been vaccinated. After lawsuits objecting to the requirement, a federal judge suspended the program in 2004, finding fault in the Food and Drug Administration's process for approving the drug. The next year, the FDA reaffirmed its finding that the vaccine was safe.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Combination vaccine developed for smallpox and anthrax

Oct 06, 2010

(PhysOrg.com) -- A new combination vaccine against both smallpox and anthrax has been tested in animal studies and found to be more effective against anthrax than the Emergent BioSolutions Inc. vaccine currently ...

Revisiting the anthrax attacks

Jan 22, 2009

When anthrax was sent through the U.S. Postal Service in 2001, an overwhelming majority of postal workers elected not to be inoculated with the available vaccine because of confusion and distrust, according to a University ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

hush1
1 / 5 (1) Nov 01, 2011
Another CIA sponsored vaccination program.
Congratulations.